Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01796171
Title A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-01)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nordic Nanovector
Indications

marginal zone B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

follicular lymphoma

mantle cell lymphoma

lymphoplasmacytic lymphoma

Therapies

Lilotomab

Betalutin

Rituximab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT


No variant requirements are available.